Application of data mining techniques in pharmacovigilance

British Journal of Clinical Pharmacology

Volumn 57, Issue 2, 2004, Pages 127-134

  Wilson, Andrew M ^a,b   Thabane, Lehana ^a,b   Holbrook, Anne ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Adverse drug events; Data mining; Knowledge discovery in databases; Pharmacovigilance

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PRACTOLOL; TERFENADINE;

CLUSTER ANALYSIS; COUGHING; DATA ANALYSIS; DATA BASE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ELECTRONICS; HEALTH CARE PERSONNEL; HUMAN; LITERATURE; MEDICAL RECORD; NOMENCLATURE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TECHNIQUE; WORLD HEALTH ORGANIZATION;

DATA COLLECTION; DATABASES, BIBLIOGRAPHIC; DATABASES, FACTUAL; HUMANS; INFORMATION STORAGE AND RETRIEVAL; PHARMACEUTICAL PREPARATIONS;

EID: 1242329171     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01968.x     Document Type: Review

References (46)

1. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. Br Med J 1998; 316: 1295-8.
2. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy 2002; 22: 915-23.
3. Juntti-Patinen L, Neuvonen PJ. Drug-related deaths in a University central hospital. Eur J Clin Pharmacol 2002; 58: 479-82.
4. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
5. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
6. Bates DW, Leape LL, Cullen DJ et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311-16.
7. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992; 52: 231-8.
8. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001; 285: 437-43.
9. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286: 954-9.
10. Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-8.
11. Edwards IR. The accelerating need for pharmacovigilance. J Roy Coll Physicians Lond 2000; 34: 48-51.
12. Friedman MA, Woodcock J, Lumpkin MM, Shuren JE, Hass AE, Thompson LJ. The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA 1999; 281: 1728-34.
13. Chakrabarti S. Mining the web: Discovering knowledge from hypertext data. Morgan Kaufmann Publishers, San Francisco, CA, 2002.
14. Chowdhury GG. Template mining for information extraction from digital documents. Library Trends 1999; 48: 181-207.
15. Kwansnik BH. The role of classification in knowledge representation and discovery. Library Trends 1999; 48: 22-47.
16. Amery WK. Signal generation from spontaneous adverse event reports. Pharmacoepidemiol Drug Saf 1999; 8: 147-50.
17. Helma C, Gottmann E, Kramer S. Knowledge discovery and data mining in toxicology. Stat Meth Med Res 2000; 9: 329-58.
18. Coulter DM, Bate A, Meyboom RH, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study, extra. Details of methods: explanation of data mining methods. Br Med J 2001; 322: 1207-9.
19. Brown EG. Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART. Drug Saf 2002; 25: 445-52.
20. Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf 1999; 20: 109-17.
21. Strom BL. How should one perform pharmacoepidemiology studies? Choosing among the available alternatives. In Pharmacoepidemiology, 3rd edn, ed Strom BL. Chichester: John Wiley & Sons Ltd, 2000; 401-13.
22. Biriell C, Edwards R. Reasons for reporting adverse drug reactions - some thoughts based on an international review. Pharmacoepidemiol Drug Saf 1997; 6: 21-6.
23. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002; 25: 381-92.
24. Mann RD. Prescription-event monitoring-recent progress and future horizons. Br J Clin Pharmacol 1998; 46: 195-201.
25. Heeley E, Wilton LV, Shakir SA. Automated signal generation in prescription-event monitoring. Drug Saf 2002; 25: 423-32.
26. Rawson NS, Rawson MJ. Acute adverse event signalling scheme using the Saskatchewan Administrative health care utilization datafiles: results for two benzodiazepines. Can J Clin Pharmacol 1999; 6: 159-66.
27. Barbone F, McMahon AD, Davey PG et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352: 1331-6.
28. Honigman B, Lee J, Rothschild J et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001; 8: 254-66.
29. Cerrito P. Application of data mining for examining polypharmacy and adverse effects in cardiology patients. Cardiovasc Toxicol 2001; 1: 177-9.
30. Niu MT, Erwin DE, Braun MM. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine 2001; 19: 4627-34.
31. Bytzer P, Hallas J. Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions. Aliment Pharmacol Ther 2000; 14: 1479-84.
32. Bagheri H, Michel F, Lapeyre-Mestre M et al. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol 2000; 50: 479-84.
33. Mey C, Hentschel H, Hippius M, Balogh A. Documentation and evaluation of adverse drug reactions (ADR) - contribution from a poison information center. Int J Clin Pharmacol Ther 2002; 40: 102-7.
34. Perner P, Petrou M. Machine learning and data mining in pattern recognition. Berlin: Springer Verlag, 1999.
35. Egberts AC, Meyboom RH, van Puijenbroek EP. Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 2002; 25: 453-8.
36. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10: 483-6.
37. Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf 2002; 25: 393-7.
38. van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG. Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Br J Clin Pharmacol 1999; 47: 689-93.
39. Lindquist M, Stahl M, Bate A, Edwards IR, Meyboom RH. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf 2000; 23: 533-42.
40. Bate A, Lindquist M, Orre R, Edwards IR, Meyboom RH. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. Eur J Clin Pharmacol 2002; 58: 483-90.
41. van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10.
42. Shakir SA, Layton D. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf 2002; 25: 467-71.
43. van Puijenbroek EP, van Grootheest K, Diemont WL, Leufkens HG, Egberts AC. Determinants of signal selection in a spontaneous reporting system for adverse drug reactions. Br J Clin Pharmacol 2001; 52: 579-86.
44. Dunn N, Freemantle S, Mann R. Nicorandil and diabetes: a nested case-control study to examine a signal generated by prescription-event monitoring. Eur J Clin Pharmacol 1999; 55: 159-62.
45. Kaufman DW, Rosenberg L, Mitchell AA. Signal generation and clarification: use of case-control data. Pharmacoepidemiol Drug Saf 2001; 10: 197-203.
46. Meyboom RH, Lindquist M, Egberts AC, Edwards IR. Signal selection and follow-up in pharmacovigilance. Drug Saf 2002; 25: 459-65.